Research Paper Volume 16, Issue 4 pp 4033—4051
LGALS3BP is a novel and potential biomarker in clear cell renal cell carcinoma
Figure 2. The expression of LGALS3BP mRNA in subgroups of ccRCC patients (UALCAN). (A) The comparative expression of LGALS3BP in normal and KIRC samples. (B) LGALS3BP expression in normal and ccRCC tissues (with or without nodal metastasis). (C) LGALS3BP expression in ccRCC patients aged 21–40, 41–60, 61–80, or 81–100. (D) Comparative expression of LGALS3BP in normal and ccRCC (stage 1, 2, 3, or 4) samples. *, p < 0.05; **, p < 0.01; ***, p < 0.001.